Cargando…
Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis
Interstitial lung disease (ILD) is a severe extra-articular manifestation of rheumatoid arthritis (RA) that is well-defined as a chronic systemic autoimmune disease. A proportion of patients with RA-associated ILD (RA-ILD) develop pulmonary fibrosis (PF), resulting in poor prognosis and increased li...
Autores principales: | Wang, Yao, Song, Wuqi, Wu, Jing, Li, Zhangming, Mu, Fengyun, Li, Yang, Huang, He, Zhu, Wenliang, Zhang, Fengmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322753/ https://www.ncbi.nlm.nih.gov/pubmed/28243535 http://dx.doi.org/10.7717/peerj.3021 |
Ejemplares similares
-
Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis
por: Xue, Jing, et al.
Publicado: (2022) -
Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis
por: Yu, Rui, et al.
Publicado: (2023) -
A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia
por: Wang, Shuhua, et al.
Publicado: (2023) -
Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012) -
Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023)